Universal Vaccines: Shifting to One for Many

被引:36
作者
Cassone, Antonio [1 ]
Rappuoli, Rino [2 ]
机构
[1] Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, I-00161 Rome, Italy
[2] Novartis Vaccines & Diagnost, Siena, Italy
来源
MBIO | 2010年 / 1卷 / 01期
关键词
INFECTIONS; REACTIVITY; PROTECTION;
D O I
10.1128/mBio.00042-10
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human vaccines, with their exquisite antigenic specificity, have greatly helped to eliminate or dramatically abate the incidence of a number of historical and current plagues, from smallpox to bacterial meningitis. Nonetheless, as new infectious agents emerge and the number of vaccine-preventable diseases increases, the practice and benefits of single-pathogen- or disease-targeted vaccination may be put at risk by constraints of timely production, formulation complexity, and regulatory hurdles. During the last influenza pandemic, extraordinary efforts by vaccine producers and health authorities have had little or no influence on disease prevention or mitigation. Recent research demonstrating the possibility of protecting against all influenza A virus types or even phylogenetically distant pathogens with vaccines based on highly conserved peptide or saccharide sequences is changing our paradigm. "Universal vaccine" strategies could be particularly advantageous to address protection from antibiotic-resistant bacteria and fungi for which no vaccine is currently available.
引用
收藏
页数:5
相关论文
共 27 条
[1]   Controlling Antimicrobial Resistance in the Hospital [J].
Anderson, Deverick J. ;
Kaye, Keith S. .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2009, 23 (04) :847-+
[2]   Immunological Reactivity of Blood from Healthy Humans to the rAls3p-N Vaccine Protein [J].
Baquir, Beverlie ;
Lin, Lin ;
Ibrahim, Ashraf S. ;
Fu, Yue ;
Avanesian, Valentina ;
Tu, Ang ;
Edwards, John, Jr. ;
Spellberg, Brad .
JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (03) :473-477
[3]  
BARBERA JP, 2009, AGING HLTH, V5, P475
[4]   Saccharomyces cerevisiae as a vaccine against coccidioidomycosis [J].
Capilla, Javier ;
Clemons, Karl V. ;
Liu, Min ;
Levine, Hillel B. ;
Stevens, David A. .
VACCINE, 2009, 27 (27) :3662-3668
[5]   Antibody-mediated protection through cross-reactivity introduces a fungal heresy into immunological dogma [J].
Casadevall, Arturo ;
Pirofski, Lilse-anne .
INFECTION AND IMMUNITY, 2007, 75 (11) :5074-5078
[6]   Fungal vaccines: real progress from real challenges [J].
Cassone, Antonio .
LANCET INFECTIOUS DISEASES, 2008, 8 (02) :114-124
[7]   Opportunistic fungi and fungal infections: the challenge of a single, general antifungal vaccine [J].
Cassone, Antonio ;
Torosantucci, Antonella .
EXPERT REVIEW OF VACCINES, 2006, 5 (06) :859-867
[8]   Attacking the flu Neutralizing antibodies may lead to 'universal' vaccine [J].
Chen, Grace L. ;
Subbarao, Kanta .
NATURE MEDICINE, 2009, 15 (11) :1251-1252
[9]   Research and development of universal influenza vaccines [J].
Du, Lanying ;
Zhou, Yusen ;
Jiang, Shibo .
MICROBES AND INFECTION, 2010, 12 (04) :280-286
[10]   M2e-based universal influenza A vaccine [J].
Fiers, Walter ;
De Filette, Marina ;
El Bakkouri, Karim ;
Schepens, Bert ;
Roose, Kenny ;
Schotsaert, Michael ;
Birkett, Ashley ;
Saelens, Xavier .
VACCINE, 2009, 27 (45) :6280-6283